How Long Should Active Surveillance of Prostate Cancer Last?

Ending active surveillance for men with low-risk prostate cancer may never be appropriate, according to a new study that saw progression and need for treatment in some patients followed-up for more than 15 years.

Related Keywords

Sweden , San Francisco , California , United States , Gothenburg , Vastra Gotalands Lan , Matthewr Cooperberg , Emmeli Palmstedt , European Association Of Urology , Sahlgrenska Academy , Department Of Urology , University Of Gothenburg , University Of California , European Association , Free Survival Falls ,